Acute kidney injury (AKI) affects approximately 60% of critically ill patients and results in substantial morbidity and mortality. 1, 2 Outcomes associated with AKI remain poor despite improved awareness. 3 One reason for this is that early detection of AKI is difficult, resulting in delays in evaluation, discontinuation of nephrotoxins, and treatment of other precipitating causes (eg, sepsis). A report from the National Confidential Enquiry into Patient Outcomes and Death from the United Kingdom showed that in 30% of patients who died of AKI, the condition was predictable and avoidable. In addition, only one-half of those patients received "good care," and many patients did not have serum creatinine (SC) measurement or calculation of urine output (UO). 4 From the Acute Dialysis Quality Initiative recommendations in 2004 5 to the most recent Kidney
Disease Improving Global Outcomes (KDIGO) guideline in 2012, 6 experts have recommended the monitoring of UO and SC for patients at risk for AKI. Creatinine and urine output are fundamental for diagnosis, severity classification, and outcome prediction in AKI, and there is increasing evidence that even small elevations in SC may be associated with worse clinical outcomes. 7, 8 Although many studies exclude UO criteria when monitoring renal function because of the technical difficulty of accurate collection and the complexity of interpretation, we have recently shown that SC criteria alone may miss about 20% of patients with AKI and may result in misclassification of AKI severity. 9 Whether intensive monitoring of SC and UO in critically ill patients is associated with increased detection of AKI and improved outcomes is not known.
In this study, we used a large intensive care database to examine the risk of AKI and outcomes associated with AKI in patients who had and those who did not have intensive monitoring of SC and UO, defined as daily and hourly, respectively.
Methods

Source Population
We analyzed data on 45,568 adult patients admitted to any of eight ICUs at the University of Pittsburgh Medical Center during an 8-year period (from July 2000-October 2008). Details of the data set are published elsewhere. 10 For this study, we applied the following exclusion criteria: (1) a history of chronic dialysis or renal transplantation, or both (n ¼ 3,600); (2) a baseline serum creatinine level $ 4 mg/dL (n ¼ 116); (3) an inability to stage AKI in the 7 days after ICU admission (n ¼ 594); (4) death within 48 hours of ICU admission (n ¼ 1,238); (5) ICU stay < 48 hours (n ¼ 16,337); and (6) no vasopressor support or mechanical ventilation in the 24 hours after ICU admission (n ¼ 7,959). The remaining 15,724 patients composed the study cohort (Fig 1) . 
Source
Definitions and Outcomes
Baseline, admission, and reference SC values were determined as previously described. 12 We defined baseline creatinine as the lowest value in the year prior to the index hospital admission. Admission creatinine levels were the first creatinine value recorded for the index hospital admission. Reference creatinine level was taken as the baseline creatinine level when available; otherwise, it was the lowest between admission creatinine level or creatinine level recorded in the 24 hours following ICU admission or (in patients without history of CKD) estimated from the Modification of Diet in Renal Disease equation for SC using a glomerular filtration rate of 75 mL/min/ 1.73m 2 , as recommended in international guidelines. 6 We classified AKI according to the maximum Kidney Disease Improving Global Outcomes criteria 6 met during the 7 days after ICU admission using both SC and UO criteria. For all analyses, we used moderate to severe AKI defined as stage 2-3. For UO criteria, we required data at least every 6 hours to stage AKI regardless of whether the patient had intensive or nonintensive UO monitoring overall. We defined fluid balance on the basis of total input/output divided by body weight and expressed as a percentage. We defined fluid overload as > 10% positive fluid balance. Primary comparisons were based on the cumulative fluid balance and fluid overload over the first 72 hours of ICU stay.
Statistical Analyses
Statistical analyses were performed using Stata software, version SE 13.1 (Stata LP), with statistical significance set at P < .05. Survival graphs were created using the R package "survival," version 2.38-1 (R Project for Statistical Computing). Comparisons across groups were performed using the c 2 asymptotic test or Fisher's exact test for categorical variables and the Kruskal-Wallis one-way analysis of variance by ranks for continuous variables. We used multivariable logistic regression to identify risk factors associated with AKI development: by intensity of UO and SC monitoring. The likelihood ratio test was used for model selection, and Wald tests were used to assess the significance of each risk factor retained in the final models. A Cox proportional hazards model was used to assess the age and APS-III-adjusted survival at 30 days after ICU admission. In the survival model, the Breslow method was used for ties, the likelihood ratio test was used to test the overall statistical significance of the model, and Wald tests were used to do pairwise comparisons between groups.
Results
Baseline Characteristics and Exposures
Of the 15,724 patients included in our study, 4,049 (25.8%) received intensive monitoring of UO compared with 12,156 (77.4%) who received intensive monitoring of SC (Fig 1) . Baseline characteristics for patients meeting and those not meeting UO and SC monitoring criteria stratified by AKI (stage 2-3) are shown in Tables 1 and 2 , respectively. Baseline characteristics (first 24 hours after ICU admission) were similar between groups, with the exception of fluid administered and vasopressor use (both greater in the nonintensive monitoring group). There were no clinically significant differences in reference creatinine levels or APS-III scores between groups based on UO monitoring.
Development of AKI
Crude rates of AKI (stage 2-3) by 7 days after ICU admission were similar between UO monitoring groups (intensive, 62.5% vs less intensive, 63.9%) and higher in the intensive SC monitoring group (intensive, 65.5% vs less intensive, 56.7%). However, after adjusting for baseline characteristics, intensive monitoring of UO was associated with greater rates of AKI (OR, 1.22; 95% CI, 1.11-1.35; P < .001). In contrast, intensive monitoring of SC was only marginally significant (OR, 1.11; 95% CI, 1.00-1.24; P ¼ .05) (Fig 2, e- Table 1 , e- Table 2 ).
Survival and Length of Stay
For patients experiencing AKI, in unadjusted analyses intensive monitoring for UO was strongly associated with improved survival to 30 days compared with patients with less intensive UO monitoring (hazard ratio [HR] , 0.85; 95% CI, 0.77-0.94; P ¼ .001). This difference was also seen after adjusting for age and severity of illness (HR, 0.90; 95% CI, 0.81-0.99; P ¼ .04) (Fig 3,  Table 3 ). In contrast, for patients not experiencing AKI, in the hospital for patients with AKI. For patients without AKI, ICU and hospital length of stay were shorter: 5 days (4-10 days) and 14 days (9-24 days), respectively, but were also not different by monitoring intensity.
Process of Care for Patients With and Those Without AKI
In an effort to better understand differences in outcomes, we examined various process of care variables for patients experiencing AKI or not stratified by UO monitoring. Taking the cohort as a whole, patients receiving intensive UO monitoring received less fluid in the first 24 hours compared with patients receiving less intensive UO monitoring: 3.6 L (2.5-5.1 L) vs 4.2 L (2.8-6.5 L) (P < .001), respectively. These patients were also less likely to receive vasopressors: 33.4% vs 49.8%; P < .001. Over the first 72 hours of ICU stay, median cumulative fluid balance was lower (2.98% vs 3.78%; P < .001) and the proportion of patients with $ 10% fluid overload was less (2.49% vs 5.68%; P < .001) with intensive UO monitoring. When we restricted the fluid overload analysis to those patients experiencing AKI, we found that the median cumulative fluid balance was again lower (3.17% vs 4.17%; P < .001) and the proportion of patients at $ 10% fluid overload was again less (2.97% vs 7.13%; P < .001) with intensive UO monitoring.
Sensitivity Analyses
Our primary analysis used stage 2-3 AKI, so we explored alternative thresholds for AKI severity-any stage AKI or stage 3 AKI-and repeated our primary analysis stratifying patients by these criteria. Our results were unchanged for 30-day survival. Next, we examined the results across different units and over the years included chestjournal.org in the database. Results were generally consistent across different ICUs and over different years, although the reduced sample size resulted in nonsignificant results for some individual units or some individual years. Finally, we examined the proportion of patients meeting UO or SC criteria, or both, for AKI stratified by intensity of UO monitoring. The distribution was similar for patients with and those without intensive monitoring, although slightly more patients met AKI criteria using UO only (and slightly fewer using both) with intensive UO monitoring (e- Table 3 ).
Discussion
Treatment of AKI is focused on supportive care and identification of the underlying cause. Both of these priorities might be improved by earlier detection of AKI and closer monitoring of kidney function. In a small study, Udy et al 13 found that more frequent measurement of SC levels with the use of a point of care test could increase detection of AKI. In another study, Macedo et al 14 found that diagnosis of AKI occurred earlier in oliguric than in nonoliguric patients. Similarly, Wlodzimirow et al 15 compared the diagnosis of AKI by UO criteria and SC criteria and found a higher incidence of AKI using UO criteria (38% vs 24%). A biopsy study found that 35% of patients with parenchymal structural changes did not meet KDIGO creatinine criteria for AKI, 16 suggesting a delayed rise in creatinine levels or "subclinical" AKI. These prior studies lay a foundation of evidence to suggest that delays in recognition of AKI are common. If these delays can be mitigated by more intense monitoring of UO, we hypothesize that outcomes may be improved.
One possible mechanism by which intensive monitoring of UO improves care and outcomes is through better fluid management. As shown in Table 1 , for patients who experienced stage 2-3 AKI, intensive monitoring of UO was associated with less fluid administered during the first 24 hours of the ICU stay compared with less intensive UO monitoring (3.6 L vs 4.2 L; P < .001), despite having more weightadjusted urine output (17.5 mL/kg vs 15.4 mL/kg; P < .001). As a result, cumulative fluid balance was reduced; however, a component of the more favorable fluid balance for patients receiving intensive UO monitoring was due to the greater UO (eg, 150 mL/d in a 70-kg patient). These findings suggest that patients receiving intensive UO monitoring may have been managed with a more conservative volume resuscitation strategy, leading to less cumulative fluid balance. Several studies have shown positive associations between higher fluid balance and higher mortality. 17, 18 However, patients receiving intensive UO monitoring were also less likely to receive vasopressors (29.9% vs 43.3%; P < .001), and this difference was seen in both patients experiencing AKI (33.4% vs 49.8%) and those who did not (23.9% vs 31.8%). This suggests that contrary to expectations, patients not receiving intensive UO monitoring were more hemodynamically unstable compared with patients who did.
Two factors may contribute to reduced measurement and recording of UO. First, measurement of UO is tedious, and accurate hourly UO calculation is sometimes difficult to achieve. Second, there has been a concerted effort in many (if not most) ICUs to discontinue Foley catheter use as early as possible. We do not know what effect these efforts may be having on the intensity of UO monitoring.
Our study has important limitations. First, despite the large sample size, the patients were all from a single medical center, and thus our results may not be 
Conclusions
In conclusion, the intensity of UO monitoring is associated with increased detection of moderate to severe AKI and reduced incidence of fluid overload and is independently associated with reduced 30-day mortality in patients experiencing AKI. In contrast, intensive monitoring of SC showed no effect on 30-day mortality associated with AKI. Our results should help inform clinical decisions and ICU policy about the frequency of monitoring of UO, especially for patients at high risk of AKI.
